Ozempic, Wegovy Potentially Linked to Rare Eye Disease in New Study

Ozempic, Wegovy Potentially Linked to Rare Eye Disease in New Study

Share on Pinterest
A new study finds people using GLP-1 drug semaglutide may have increased risk of a rare blinding disease. Getty Images/Westend61
  • Semaglutide, the active ingredient in Ozempic and Wegovy, is associated with a rare blinding disease, according to new research.
  • The condition, known…

[ad_2]

Source link

More From Author

The three ‘best sources’ of dietary collagen to delay the appearance of wrinkles and sagging

The three ‘best sources’ of dietary collagen to delay the appearance of wrinkles and sagging

FDA Authorizes Rapid Point-of-Care Hepatitis C Test – The Presidential Prayer Team

FDA Authorizes Rapid Point-of-Care Hepatitis C Test – The Presidential Prayer Team

Leave a Reply

Your email address will not be published. Required fields are marked *